Tianjin Juliang issues a special plan to support pharmaceutical assets, and the project draws on scientific and technological forces such as blockchain

On March 30, it was learned from the Tianjin Development Zone Management Committee that Tianjin Juliang Commercial Factoring Co., Ltd., an enterprise in the zone, as an asset service agency and sales agency, successfully issued the Hongta Securities-Juliang factoring pharmaceutical asset support special plan (Control), the project successfully leveraged smart technology such as the Internet of Things and blockchain to break through the traditional risk assessment model of financial institutions and became the first domestic ABS (asset securitization) product to be issued based solely on transaction credit, with a total size of 128 million Yuan, the initial stakeholder is a subsidiary of Neptune Biogroup.